49 phenotypes from 5 alleles in 5 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Cbltm1b(EUCOMM)Hmgu/Cbl+ C57BL/6N-Cbltm1b(EUCOMM)Hmgu/Orl	prolonged PR interval	J:211773
	thick ventricular wall	J:211773
Cbltm1b(EUCOMM)Hmgu/Cbltm1b(EUCOMM)Hmgu C57BL/6N-Cbltm1b(EUCOMM)Hmgu/Orl	preweaning lethality, incomplete penetrance	J:211773
Cbltm1Ddlb/Cbl+ involves: 129S1/Sv * C57BL/6	decreased white adipose tissue amount	J:94416
	improved glucose tolerance	J:121012
	increased body weight	J:121012
	increased susceptibility to diet-induced obesity	J:121012
Cbltm1Ddlb/Cbltm1Ddlb involves: 129S1/Sv	abnormal myeloblast morphology/development	J:81965
	abnormal T cell physiology	J:81965
	enlarged spleen	J:81965
	increased spleen red pulp amount	J:81965
	spleen hyperplasia	J:81965
Cbltm1Ddlb/Cbltm1Ddlb involves: 129S1/Sv * C57BL/6	abnormal fat cell morphology	J:94416
	abnormal gas homeostasis	J:94416
	abnormal glucose homeostasis	J:94416
	abnormal lipid homeostasis	J:94416
	abnormal muscle physiology	J:94416
	decreased circulating free fatty acids level	J:94416
	decreased circulating insulin level	J:94416
	decreased circulating leptin level	J:94416
	decreased liver triglyceride level	J:94416
	decreased respiratory quotient	J:94416
	decreased total body fat amount	J:94416
	enlarged spleen	J:103366
	improved glucose tolerance	J:94416
	increased body temperature	J:94416
	increased insulin sensitivity	J:94416
	increased lean body mass	J:94416
	increased locomotor activity	J:94416
	increased mitochondrial size	J:94416
	increased muscle cell glucose uptake	J:94416
	increased oxygen consumption	J:94416
	increased spleen red pulp amount	J:103366
	polyphagia	J:94416
	spleen hyperplasia	J:103366
Cbltm1Ddlb/Cbltm1Ddlb involves: 129S1/Sv * C57BL/6J	abnormal bone marrow cell morphology/development	J:76895
	abnormal branching of the mammary ductal tree	J:76895
	abnormal lymph node cell ratio	J:76895
	abnormal mammary fat pad morphology	J:76895
	abnormal spleen morphology	J:76895
	abnormal splenic cell ratio	J:76895
	abnormal thymus cell ratio	J:76895
	enlarged lymph nodes	J:76895
	enlarged spleen	J:76895
	extramedullary hematopoiesis	J:76895
	normal skeleton phenotype	J:76895
	thrombocytosis	J:76895
Cbltm1Dejs/Cbltm1Dejs involves: 129S1/Sv * C57BL/6	normal growth/size/body region phenotype	J:121012
	normal homeostasis/metabolism phenotype	J:121012
Cbltm1Soga/Cbltm1Soga Not Specified	enlarged spleen	J:151543
	increased hematopoietic stem cell number	J:151543
Cbltm1Wlan/Cbltm1Wlan involves: 129S1/Sv * C57BL/6	abnormal myeloblast morphology/development	J:81965
	abnormal T cell physiology	J:81965
	dilated oviduct	J:81965
	dilated uterus	J:81965
	enlarged spleen	J:81965
	increased spleen red pulp amount	J:81965
	myeloid hyperplasia	J:81965
	postnatal lethality	J:81965
	spleen hyperplasia	J:81965